Product Browser

Last updated: 2017/4/23

Product Compare

Product Compare Cancel Click this icon to add products to compare list. Select up to 10 products.

Quick Order (Tutorial)

Input Catalog #,
place order here!
Catalog # :
  • Where to buy
  • Choose your location

MAGEA3 293T Cell Transient Overexpression Lysate(Denatured)

  • Catalog # : H00004102-T01
  • Visit Frequency :
  • Countries :
  • Specification
  • Transfected Cell Line:
  • 293T
  • Plasmid:
  • pCMV-MAGEA3 full-length
  • Host:
  • Human
  • Theoretical MW (kDa):
  • 34.65
  • Quality Control Testing:
  • Transient overexpression cell lysate was tested with Anti-MAGEA3 antibody (H00004102-B01) by Western Blots.
    Western Blot
    QC Testing of H00004102-T01
    Lane 1: MAGEA3 transfected lysate ( 34.65 KDa)
    Lane 2: Non-transfected lysate.
    SDS-PAGE Gel
    QC Testing of H00004102-T01
    MAGEA3 transfected lysate.
  • Storage Buffer:
  • 1X Sample Buffer (50 mM Tris-HCl, 2% SDS, 10% glycerol, 300 mM 2-mercaptoethanol, 0.01% Bromophenol blue)
  • Storage Instruction:
  • Store at -80°C. Aliquot to avoid repeated freezing and thawing.
  • Applications
  • Western Blot
  • Application Image
  • Western Blot
  • Gene Information
  • Entrez GeneID:
  • 4102
  • Gene Name:
  • MAGEA3
  • Gene Alias:
  • HIP8,HYPD,MAGE3,MAGEA6,MGC14613
  • Gene Description:
  • melanoma antigen family A, 3
  • Gene Summary:
  • This gene is a member of the MAGEA gene family. The members of this family encode proteins with 50 to 80% sequence identity to each other. The promoters and first exons of the MAGEA genes show considerable variability, suggesting that the existence of this gene family enables the same function to be expressed under different transcriptional controls. The MAGEA genes are clustered at chromosomal location Xq28. They have been implicated in some hereditary disorders, such as dyskeratosis congenita. [provided by RefSeq
  • Other Designations:
  • MAGE-3 antigen,OTTHUMP00000024220,antigen MZ2-D,melanoma-associated antigen 3
  • RSS
  • YouTube
  • Linkedin
  • Facebook